U.S. Customs and Border Protection officers in Cincinnati intercepted approximately 5,000 individual shipments of unapproved ...

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss ...

China's fast-growing market for GLP-1 weight-loss drugs is bracing for a major shake-up as the core compound patent for semaglutide was expiring in March, opening the door for multiple domestic ...

A Utah licensed Osteopathic Physician has been federally indicted after he allegedly received, recommended, and sold ...

The simultaneous patent expiry of Ozempic in China and India has seen generic makers jump in. Low cost production in high ...

China has granted approval for a Pfizer GLP-1 based medication for weight management, marking a significant milestone in the country’s rapidly expanding market for obesity and metabolic-health ...

The company has not disclosed pricing or a launch timeline. The approval also comes as Novo Nordisk's Wegovy nears patent expiry later this month, potentially paving the way for lower-cost copycat ...

April 1 (Reuters) - Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the ...

China’s BrightGene has served up a slice of early-stage data to remind everyone it has a horse in the oral obesity race.  | ...

When Wang Zhucen signed up for the first-ever weight management course at Dalian University of Technology in the northeastern ...